{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0115-1724",
      "generic_name": "Ultramicrosize Griseofulvin Tablets",
      "labeler_name": "Amneal Pharmaceuticals of New York LLC",
      "brand_name": "Ultramicrosize Griseofulvin",
      "active_ingredients": [
        {
          "name": "GRISEOFULVIN",
          "strength": "125 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0115-1724-01",
          "description": "100 TABLET, COATED in 1 BOTTLE, PLASTIC (0115-1724-01)",
          "marketing_start_date": "20140929",
          "sample": false
        },
        {
          "package_ndc": "0115-1724-02",
          "description": "500 TABLET, COATED in 1 BOTTLE, PLASTIC (0115-1724-02)",
          "marketing_start_date": "20140929",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, COATED",
      "spl_id": "0fe90733-bebc-42d5-a098-8f53ad6fab67",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20140929",
      "product_id": "0115-1724_0fe90733-bebc-42d5-a098-8f53ad6fab67",
      "application_number": "ANDA204371",
      "brand_name_base": "Ultramicrosize Griseofulvin",
      "pharm_class": [
        "Decreased Mitosis [PE]",
        "Microtubule Inhibition [PE]",
        "Tubulin Inhibiting Agent [EPC]"
      ]
    }
  ]
}